Mozart Therapeutics
Latest round
- Series A
Last raised
- Jun 2023
Total raised
- $80M
Investors
- 11
About Mozart Therapeutics
Founded in 2020, Mozart Therapeutics is dedicated to creating therapies for autoimmune conditions.Mozart Therapeutics specializes in the development of innovative biologics targeting autoimmune diseases. Key offerings include first-in-class CD8 Treg modulators that address immune dysregulation.Mozart Therapeutics generates revenue through partnerships and collaborations with research institutions, focusing on clinical development agreements that may include licensing and milestone payments.
Who invested in Mozart Therapeutics
11 investors across 2 rounds
See all investors in Mozart Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Mozart Therapeutics
Who invested in Mozart Therapeutics?
Mozart Therapeutics has 11 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mozart Therapeutics raised?
Mozart Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Mozart Therapeutics last raise money?
Mozart Therapeutics's most recent round on record is a Series A, in Jun 2023.
What does Mozart Therapeutics do?
Founded in 2020, Mozart Therapeutics is dedicated to creating therapies for autoimmune conditions.
Where is Mozart Therapeutics headquartered?
Mozart Therapeutics is headquartered in Seattle, US.
Which VCs invest in companies like Mozart Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Mozart Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Mozart Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.